NAV
32.56(-0.45%)Fund Size (CR)
₹85.19Expense Ratio
1.22Scheme Type
Active FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹500Minimum SIP Investment
₹100Minimum Withdrawal
₹500Exit Load
0%Return Since Launch
19.58%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Karan Doshi
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 6 October 2025 | 10144.67 | 1.45% | - | 0.41% | 93/920 |
1 Month | 12 September 2025 | 10050.63 | 0.51% | - | 0.30% | 358/916 |
3 Month | 11 July 2025 | 10265.39 | 2.65% | - | 1.34% | 209/880 |
6 Month | 11 April 2025 | 10954.10 | 9.54% | - | 14.80% | 750/860 |
1 Year | 11 October 2024 | 10057.68 | 0.58% | 0.58% | -0.57% | 266/756 |
3 Year | 13 October 2022 | 18173.22 | 81.73% | 22.01% | 20.59% | 174/494 |
5 Year | 13 October 2020 | 20280.10 | 102.80% | 15.18% | 22.73% | 353/394 |
Since Inception | 28 February 2019 | 32711.80 | 227.12% | 19.58% | 13.54% | 194/920 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 4 November 2024 | 1,20,000 | 124652.13 | 3.88% | 3.88% |
3 Year | 1 November 2022 | 3,60,000 | 491564.78 | 36.55% | 10.94% |
5 Year | 2 November 2020 | 6,00,000 | 919690.73 | 53.28% | 8.92% |
10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.49%
Standard Deviation
0.78%
Beta
0.95%
Sharpe Ratio
-0.00%
Treynor's Ratio
11.01%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
---|---|---|---|---|---|
Sun Pharma.Inds. | 10.08% | 53851 | 8.59 | Equity | Pharmaceuticals |
Apollo Hospitals | 5.85% | 6723 | 4.98 | Equity | Healthcare |
Torrent Pharma. | 5.55% | 13130 | 4.73 | Equity | Pharmaceuticals |
Cipla | 5.51% | 31218 | 4.69 | Equity | Pharmaceuticals |
Fortis Health. | 4.79% | 42102 | 4.08 | Equity | Healthcare |
Piramal Pharma | 4.45% | 198385 | 3.79 | Equity | Pharmaceuticals |
Neuland Labs. | 4.14% | 2414 | 3.53 | Equity | Pharmaceuticals |
Divi's Lab. | 4.11% | 6158 | 3.50 | Equity | Pharmaceuticals |
Aurobindo Pharma | 3.98% | 31301 | 3.39 | Equity | Pharmaceuticals |
Alkem Lab | 3.96% | 6212 | 3.37 | Equity | Pharmaceuticals |
Peer Comparison
Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
LIC MF Healthcare Fund - Direct (G) | 85.19 | 0.51% | 2.65% | 9.54% | 0.58% | 22.01% | |
Nippon India Taiwan Equity Fund - Direct (G) | 406.67 | -0.23% | 22.00% | 82.69% | 41.91% | 42.01% | |
Nippon India Taiwan Equity Fund - Direct (IDCW) | 406.67 | -0.23% | 22.00% | 82.69% | 41.91% | 42.01% | |
Aditya Birla SL International Equity Fund - Direct (G) | 266.19 | -0.28% | 7.78% | 28.88% | 26.05% | 19.55% | |
Aditya Birla SL International Equity Fund - Direct (IDCW) | 266.19 | -0.28% | 7.78% | 28.88% | 26.05% | 19.55% | |
Franklin Asian Equity Fund - Direct (G) | 279.13 | 4.59% | 11.90% | 32.68% | 16.44% | 15.74% |
List of Schemes under LIC Mutual Fund
News
LIC Mutual Fund announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme
LIC Mutual Fund has announced 25 September 2025 as the record date for the declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the following scheme. The amount of IDCW (Rs per unit) will be:LIC MF Aggressive Hybrid Fund ' Regular Plan - IDCW Option: 0.20
Powered by Capital Market - Live News
LIC Mutual Fund announces change in Key Personnel
LIC Mutual Fund has announced the Mr. Sat Pal Bhanoo has been appointed as an Associate Director and Key Personnel on the Board of LIC Funds Management Limited With effect from 12 September 2025Details of Mr. Sat Pal Bhanoo
Age: 59 years
Designation: Associate Director
Qualification: Bachelor of Arts (BA) Honours in History
Powered by Capital Market - Live News
LIC Mutual Fund announces change in fund manager under its schemes
LIC Mutual Fund has announced change in fund manager under the following schemes, With effect from 01 September 2025.Change in Fund Manager:
Scheme Name Existing Fund Managers New Fund Managers LIC MF Overnight Fund Mr. Rahul Singh Mr. Rahul Singh
Mr. Aakash DhuliaLIC MF Liquid Fund Mr. Rahul Singh Mr. Rahul Singh
Mr. Aakash DhuliaPowered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
8 February 2019
Total AUM (Cr)
₹85.19
LIC MF Healthcare Fund - Direct (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, LIC Mutual Fund. Launched in 8 February 2019, this fund is managed by Karan Doshi. With assets under management (AUM) worth ₹85.19 (Cr), as of 14 October 2025, LIC MF Healthcare Fund - Direct (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 19.58% since its launch.
The current NAV of LIC MF Healthcare Fund - Direct (G) is ₹32.56, as on 14 October 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in LIC MF Healthcare Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
Nil - If units of the Scheme are redeemed or switched out up to 12% of the units within 90 days from the date of allotment. 1.00% of the applicable NAV, If units of the scheme are redeemed or switched out in excess of the limit within 90 days from the date of allotment. Nil, If units of scheme are redeemed or switched out after 90 days from the date of allotment. The fund has generated 22.01% and 15.18% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 97.82% in Equity, 2.77% in Debt and -0.59% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 64.34% in Pharmaceuticals & Biotech, 24.62% in Healthcare Services, 5.79% in Debt, 5.37% in Chemicals & Petrochemical, -0.14% in Cash & Others